ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3,1,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
3,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
4,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
5,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
6,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
7,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,Y
8,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
9,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
10,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
11,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
11,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
11,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
12,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
12,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
13,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
14,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
15,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
16,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
17,1,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
17,2,Mycobacterial infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
18,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,Y
19,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,Y
20,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
21,1,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
22,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
23,1,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
24,1,Cerebral toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,Y
25,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
26,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
26,2,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
27,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
27,2,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
28,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
29,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
29,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
30,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
31,1,Erythropenia,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
31,2,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
32,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
32,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
33,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
33,2,Radiation pneumonitis,Radiation injuries,Injuries by physical agents,Inj&P,Y
33,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
34,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
35,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
35,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
36,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
37,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,Y
37,2,Anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
37,3,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
37,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
38,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
39,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
39,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
40,1,Hypoplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
40,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
41,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
42,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
43,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,Y
44,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
44,2,Retroperitoneal fibrosis,Peritoneal and retroperitoneal fibrosis and adhesions,Peritoneal and retroperitoneal conditions,Gastr,Y
45,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
46,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
46,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
46,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
47,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
47,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
47,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
48,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
48,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
49,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
50,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
50,2,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
50,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
50,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
51,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
51,2,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
51,3,Thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
52,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
52,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
53,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,Y
53,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
53,3,Hepatitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
54,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,Y
54,2,Hepatitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
55,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
55,2,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
55,3,Hepatitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
55,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
55,5,Pneumonia viral,Viral infections NEC,Viral infectious disorders,Infec,N
56,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,Y
56,2,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
56,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
56,4,Hepatitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
57,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
57,2,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
58,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
58,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
59,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
59,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
60,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
60,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
60,3,Pneumonia viral,Viral infections NEC,Viral infectious disorders,Infec,N
61,1,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
61,2,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
62,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
63,1,Corneal deposits,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
63,2,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
63,3,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
64,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
64,2,Coma,Coma states,Neurological disorders NEC,Nerv,N
64,3,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
64,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
64,5,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
64,6,Enterococcal sepsis,Enterococcal infections,Bacterial infectious disorders,Infec,N
64,7,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
64,8,Grimacing,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
64,9,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
64,10,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
64,11,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
64,12,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
64,13,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
64,14,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
64,15,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
65,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,Y
65,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
65,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
65,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
65,5,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
65,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
66,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
67,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
67,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
67,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
67,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
68,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
68,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
68,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
69,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
69,2,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
70,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
70,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
70,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
71,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
72,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
73,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
73,2,Coombs direct test positive,Blood grouping and cross-matching analyses,Haematology investigations (incl blood groups),Inv,N
73,3,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
73,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
73,5,Polychromasia,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
73,6,Reticulocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
73,7,Spherocytic anaemia,Red cell membrane and enzyme abnormalities,Haemolyses and related conditions,Blood,N
74,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
75,1,Anal cancer,Anal canal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
75,2,Anal skin tags,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
75,3,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
75,4,Spleen disorder,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
76,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
77,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
77,2,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
77,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
78,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
79,1,Cytomegalovirus enterocolitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
79,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
79,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
80,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
80,2,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
81,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
82,1,Soft tissue necrosis,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
83,1,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
83,2,Gastroenteritis cryptosporidial,Cryptosporidia infections,Protozoal infectious disorders,Infec,N
83,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
83,4,Pneumococcal sepsis,Streptococcal infections,Bacterial infectious disorders,Infec,N
84,1,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
85,1,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
85,2,Retinitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
86,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
86,2,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
87,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
87,2,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
88,1,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
88,2,Pneumonia fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
88,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
88,4,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
89,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
90,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
90,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
90,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
90,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
90,5,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
90,6,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
90,7,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
90,8,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
90,9,Nodular regenerative hyperplasia,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
90,10,Obliterative bronchiolitis,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
90,11,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
90,12,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
90,13,Portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
90,14,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
90,15,Varices oesophageal,Oesophageal varices,Gastrointestinal vascular conditions,Gastr,N
90,16,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
91,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
92,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
92,2,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
92,3,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
92,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
92,5,Pulmonary hilum mass,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
92,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
93,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
94,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
95,1,Arterial haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
95,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
95,3,Scedosporium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
95,4,Systemic mycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
95,5,Tracheostomy malfunction,Respiratory tract and thoracic cavity procedural complications,Procedural related injuries and complications NEC,Inj&P,N
96,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
96,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
96,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
97,1,Dermatomyositis,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
98,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
98,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
99,1,Cytomegalovirus enterocolitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
99,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
99,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
100,1,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
101,1,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
102,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
102,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
103,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
104,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
104,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
104,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
104,4,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
105,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
105,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
106,1,Complications of bone marrow transplant,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
106,2,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
107,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
107,2,Complications of bone marrow transplant,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
107,3,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
107,4,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
108,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
108,2,Complications of bone marrow transplant,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
108,3,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
109,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
109,2,Complications of bone marrow transplant,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
109,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
109,4,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
110,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
110,2,Pneumonia adenoviral,Adenoviral infections,Viral infectious disorders,Infec,N
110,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
111,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
112,1,Debridement,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
112,2,Neoplasm skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
112,3,Oesophageal squamous cell carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
112,4,Oesophagectomy,Oesophageal therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
112,5,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
112,6,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
112,7,Skin lesion removal,Skin lesion excisions,Skin and subcutaneous tissue therapeutic procedures,Surg,N
112,8,Sweat gland tumour,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
112,9,Sweat gland tumour,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
113,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
114,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
115,1,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
115,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
115,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
115,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
115,5,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
116,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
116,2,Klebsiella sepsis,Klebsiella infections,Bacterial infectious disorders,Infec,N
117,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
118,1,Central nervous system lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
118,2,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
118,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
118,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
118,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
119,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
119,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
119,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
119,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
120,1,Brachial plexopathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
120,2,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
120,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
120,4,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
120,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
121,1,Areflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
121,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
121,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
121,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
121,5,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
122,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
123,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
124,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
125,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
125,2,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
125,3,Amyloidosis,Amyloidoses,Immune disorders NEC,Immun,N
125,4,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
125,5,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
125,6,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
125,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
125,8,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
125,9,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
125,10,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
125,11,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
125,12,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
126,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
126,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
126,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
126,4,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
127,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
128,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
129,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
129,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
130,1,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
130,2,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
130,3,Retinal degeneration,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
130,4,Retinal depigmentation,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
130,5,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
130,6,Vitreous haemorrhage,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
131,1,Retinal degeneration,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
131,2,Retinal depigmentation,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
132,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
132,2,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
132,3,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
132,4,Orbital oedema,"Orbital structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
132,5,Retinal degeneration,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
132,6,Retinal depigmentation,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
133,1,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
133,2,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
133,3,Retinal degeneration,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
133,4,Retinal depigmentation,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
133,5,Vitreous haemorrhage,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
134,1,IIIrd nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
135,1,Vitreous haemorrhage,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
136,1,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
136,2,IIIrd nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
136,3,Orbital oedema,"Orbital structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
136,4,Retinal degeneration,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
136,5,Retinal depigmentation,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
137,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
137,2,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
137,3,IIIrd nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
138,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
138,2,Retinal degeneration,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
138,3,Retinal depigmentation,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
138,4,Vitreous haemorrhage,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
139,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
140,1,Sarcoma of skin,Soft tissue sarcomas histology unspecified,Soft tissue neoplasms malignant and unspecified,Neopl,N
141,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
141,2,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
141,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
142,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
142,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
142,3,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
142,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
142,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
143,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
143,2,Pathological fracture,Fractures NEC,Fractures,Musc,N
144,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
144,2,Occupational exposure to product,Occupational exposures,"Exposures, chemical injuries and poisoning",Inj&P,N
145,1,Cross sensitivity reaction,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
145,2,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
145,3,Occupational exposure to product,Occupational exposures,"Exposures, chemical injuries and poisoning",Inj&P,N
146,1,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
146,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,Y
146,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
147,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
147,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
148,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
149,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
149,2,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
149,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
150,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
150,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
150,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
150,4,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
151,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
152,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
152,2,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
152,3,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
152,4,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
152,5,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
152,6,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
152,7,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
152,8,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
152,9,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
152,10,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
152,11,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
152,12,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
152,13,Spinal stenosis,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
152,14,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
152,15,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
153,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
153,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
153,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
153,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
154,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
155,1,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,Y
156,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
156,2,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
156,3,Hypoproteinaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
156,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
156,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
156,6,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
157,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
157,2,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
157,3,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
157,4,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
157,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
157,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
157,7,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
157,8,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
157,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
157,10,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
157,11,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
157,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
157,13,Post herpetic neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
157,14,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
157,15,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
158,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
158,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
158,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
158,4,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
158,5,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
158,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
158,7,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
158,8,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
158,9,Prostatic obstruction,"Prostatic signs, symptoms and disorders NEC",Prostatic disorders (excl infections and inflammations),Repro,N
158,10,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
159,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
159,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
160,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
161,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
161,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
161,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
161,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
161,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
161,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
161,7,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
161,8,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
162,1,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
162,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
162,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
163,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
164,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
164,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
164,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
164,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
164,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
164,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
165,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
166,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
167,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
167,2,Non-cardiac chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
168,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
168,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
169,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
169,2,Premature menopause,Menopausal effects NEC,Menopause related conditions,Repro,N
170,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
171,1,Abdominal lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
171,2,Biliary obstruction,Obstructive bile duct disorders (excl neoplasms),Bile duct disorders,Hepat,N
171,3,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
171,4,Retroperitoneal lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
171,5,Richter's syndrome,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
172,1,Ovarian failure,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
173,1,Diarrhoea infectious,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
173,2,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,Y
173,3,Enterobacter infection,Enterobacter infections,Bacterial infectious disorders,Infec,N
173,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
173,5,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
173,6,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
173,7,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
173,8,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
174,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
175,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
176,1,Chronic graft versus host disease in intestine,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
176,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
176,3,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
176,4,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
176,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
176,6,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
177,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
178,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
179,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
180,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
181,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
182,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
183,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
184,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
185,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
186,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
187,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
188,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
189,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
190,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
190,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
191,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
192,1,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
192,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
192,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
193,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
193,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
193,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
193,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
193,5,Disturbance in social behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
193,6,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
193,7,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
193,8,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
193,9,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
193,10,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
193,11,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
193,12,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
193,13,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
193,14,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
193,15,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
194,1,Activated partial thromboplastin time shortened,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
194,2,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
194,3,Apoptosis,Cell metabolism disorders NEC,Metabolism disorders NEC,Metab,N
194,4,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
194,5,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
194,6,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
194,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
194,8,Gastrointestinal wall thickening,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
194,9,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
194,10,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
194,11,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
194,12,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
194,13,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
194,14,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
194,15,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
195,1,Bedridden,Disability issues,Lifestyle issues,SocCi,N
195,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
195,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
195,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
195,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
195,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
195,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
195,8,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
195,9,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
196,1,Acute myeloid leukaemia recurrent,Leukaemias acute myeloid,Leukaemias,Neopl,Y
196,2,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
196,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
197,1,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
197,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
198,1,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
198,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
199,1,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
199,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
200,1,Hodgkin's disease refractory,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
200,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
201,1,Administration related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
201,2,Autonomic nervous system imbalance,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
201,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
201,4,Retinal ischaemia,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
201,5,VIth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
202,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
203,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
203,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
204,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
204,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
204,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
204,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
204,5,Disturbance in social behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
204,6,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
204,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
204,8,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
204,9,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
205,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
205,2,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
205,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
205,4,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
206,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
207,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
207,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
207,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
207,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
207,5,Disturbance in social behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
207,6,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
207,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
207,8,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
207,9,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
208,1,Diarrhoea infectious,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
208,2,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,Y
208,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
208,4,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
208,5,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
208,6,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
209,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
209,2,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
209,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
210,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
210,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
210,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
211,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
211,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
211,3,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
212,1,Actinic keratosis,Skin preneoplastic conditions NEC,Cornification and dystrophic skin disorders,Skin,N
212,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
212,3,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
212,4,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
212,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
212,6,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
212,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
213,1,Human herpesvirus 6 infection reactivation,Herpes viral infections,Viral infectious disorders,Infec,N
213,2,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
213,3,Mucoepidermoid carcinoma of salivary gland,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
213,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
213,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
214,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
214,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
215,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
215,2,Embryonal rhabdomyosarcoma,Rhabdomyosarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
215,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
215,4,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
216,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
216,2,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
216,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
216,4,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
217,1,Human herpesvirus 6 infection reactivation,Herpes viral infections,Viral infectious disorders,Infec,N
217,2,Mucoepidermoid carcinoma of salivary gland,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
217,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
218,1,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
218,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
219,1,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
219,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
220,1,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
220,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
221,1,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
221,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
222,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
222,2,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
222,3,Infection reactivation,Infections NEC,Infections - pathogen unspecified,Infec,N
222,4,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
222,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
222,6,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
222,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
223,1,Human herpesvirus 6 infection reactivation,Herpes viral infections,Viral infectious disorders,Infec,N
223,2,Mucoepidermoid carcinoma of salivary gland,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
223,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
224,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
224,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
225,1,Human herpesvirus 6 infection reactivation,Herpes viral infections,Viral infectious disorders,Infec,N
225,2,Mucoepidermoid carcinoma of salivary gland,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
225,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
225,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
226,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
226,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
227,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
227,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
227,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
228,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
228,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
229,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
230,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
230,2,Atypical mycobacterial infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
230,3,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
230,4,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
230,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
230,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
230,7,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
230,8,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
230,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
231,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
231,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
231,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
231,4,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
232,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
232,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
232,3,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
232,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
232,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
232,6,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
232,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
233,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
233,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
233,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
233,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
233,5,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
233,6,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
233,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
233,8,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
233,9,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
233,10,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
233,11,Still's disease,Rheumatoid arthropathies,Joint disorders,Musc,N
234,1,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
234,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
234,3,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
234,4,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
234,5,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
234,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
234,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
234,8,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
235,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
235,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
235,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
235,4,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
235,5,Serratia infection,Serratia infections,Bacterial infectious disorders,Infec,N
236,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
236,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
236,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
236,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
237,1,Acute graft versus host disease in intestine,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
237,2,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
237,3,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
237,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
237,5,Fasciitis,Musculoskeletal and connective tissue infections and inflammations NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
237,6,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
237,7,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
237,8,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
237,9,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
238,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,Y
239,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
240,1,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
240,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
240,3,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
240,4,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
240,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
240,6,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
240,7,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
240,8,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
240,9,Hypovolaemia,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
240,10,Oedema blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
240,11,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
240,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
240,13,Renal injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
240,14,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
240,15,Skin oedema,Skin vascular conditions NEC,Skin vascular abnormalities,Skin,N
240,16,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
240,17,Toxic erythema of chemotherapy,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
241,1,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
241,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
241,3,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
241,4,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
241,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
241,6,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
241,7,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
241,8,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
241,9,Hypovolaemia,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
241,10,Oedema blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
241,11,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
241,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
241,13,Renal injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
241,14,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
241,15,Skin oedema,Skin vascular conditions NEC,Skin vascular abnormalities,Skin,N
241,16,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
241,17,Toxic erythema of chemotherapy,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
242,1,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
242,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
242,3,Toxic erythema of chemotherapy,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
243,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
244,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
244,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
244,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
245,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
246,1,Cryptosporidiosis infection,Cryptosporidia infections,Protozoal infectious disorders,Infec,Y
246,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
246,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
246,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
247,1,Cryptosporidiosis infection,Cryptosporidia infections,Protozoal infectious disorders,Infec,N
247,2,Encephalitis cytomegalovirus,Cytomegaloviral infections,Viral infectious disorders,Infec,N
247,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
247,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
248,1,Oesophageal adenocarcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
249,1,Encephalitis mumps,Mumps viral infections,Viral infectious disorders,Infec,Y
249,2,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
249,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
250,1,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
250,2,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
250,3,Growth retardation,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
250,4,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
250,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
250,6,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
250,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
250,8,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
251,1,Cryptosporidiosis infection,Cryptosporidia infections,Protozoal infectious disorders,Infec,N
251,2,Encephalitis cytomegalovirus,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
251,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
251,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
252,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,Y
252,2,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
252,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
252,4,Parotitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
253,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
253,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
253,3,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
253,4,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
253,5,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
254,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
254,2,Herpes zoster meningoencephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
254,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
254,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
254,5,Papilloma,Neoplasms benign site unspecified NEC,Miscellaneous and site unspecified neoplasms benign,Neopl,N
254,6,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
255,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
255,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
255,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
255,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
255,5,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
256,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
256,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
256,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
257,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
257,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
257,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
257,4,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
258,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
258,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
259,1,Chronic respiratory disease,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
259,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
259,3,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
259,4,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
259,5,Obliterative bronchiolitis,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
259,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
259,7,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
260,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
260,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
261,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
261,2,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
261,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
261,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
261,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
262,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
262,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
262,3,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
263,1,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
263,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
264,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
264,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
264,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
265,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
265,2,Toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
266,1,Cryptosporidiosis infection,Cryptosporidia infections,Protozoal infectious disorders,Infec,N
266,2,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
266,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
266,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
266,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
267,1,Acute myeloid leukaemia recurrent,Leukaemias acute myeloid,Leukaemias,Neopl,Y
267,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
267,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
267,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
267,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
268,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
268,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
268,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
268,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
268,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
268,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
269,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
269,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
270,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
270,2,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
271,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
271,2,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
271,3,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
271,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
271,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
272,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,Y
272,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
273,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
273,2,Parainfluenzae virus infection,Parainfluenzae viral infections,Viral infectious disorders,Infec,Y
274,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
274,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
274,3,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
274,4,Rotavirus infection,Rotaviral infections,Viral infectious disorders,Infec,N
274,5,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
274,6,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
275,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
276,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
276,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
276,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
276,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
277,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
277,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
277,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
277,4,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
277,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
277,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
278,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
278,2,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
278,3,Rotavirus infection,Rotaviral infections,Viral infectious disorders,Infec,N
278,4,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
279,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
279,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
279,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
280,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
280,2,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
281,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
282,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
283,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
284,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
285,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
286,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
287,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
288,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
289,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
290,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
291,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
292,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
293,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
294,1,Cystoid macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
295,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
296,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
297,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
297,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
297,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
298,1,Cystoid macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
298,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
299,1,Cystoid macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
299,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
300,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
300,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
300,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
301,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
301,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
301,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
302,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
302,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
303,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
304,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
305,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
306,1,Cytomegalovirus enterocolitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
306,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
307,1,Actinic keratosis,Skin preneoplastic conditions NEC,Cornification and dystrophic skin disorders,Skin,N
307,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
307,3,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
307,4,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
307,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
307,6,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
307,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
308,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
308,2,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,N
308,3,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
308,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
308,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
308,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
308,7,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
308,8,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
308,9,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
309,1,Cytomegalovirus enterocolitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
309,2,Gastrointestinal inflammation,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
309,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
310,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
310,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
310,3,Product preparation error,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
310,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
310,5,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
310,6,Wrong dose,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
311,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
311,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
311,3,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
311,4,Hypoglycaemia neonatal,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
311,5,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
311,6,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
311,7,Short stature,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
312,1,Clonal haematopoiesis,Haematological disorders,Haematological disorders NEC,Blood,N
312,2,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,Y
312,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
313,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,Y
314,1,Clostridial sepsis,Clostridia infections,Bacterial infectious disorders,Infec,Y
315,1,Clostridial sepsis,Clostridia infections,Bacterial infectious disorders,Infec,Y
316,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
317,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
318,1,Acquired gene mutation,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
318,2,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
318,3,Clonal haematopoiesis,Haematological disorders,Haematological disorders NEC,Blood,N
319,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
319,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
320,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
320,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
320,3,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
320,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
320,5,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
320,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
320,7,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
320,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
321,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
322,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
322,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
322,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
322,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
322,5,Disturbance in social behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
322,6,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
322,7,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
322,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
322,9,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
322,10,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
323,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
323,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
324,1,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
325,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
326,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
326,2,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
326,3,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
326,4,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
326,5,Alcohol abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
326,6,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
326,7,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
326,8,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
326,9,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
326,10,Disturbance in social behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
326,11,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
326,12,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
326,13,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
326,14,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
326,15,Intentional device misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
326,16,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
326,17,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
326,18,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
326,19,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
326,20,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
326,21,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
327,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
328,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
328,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
329,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
329,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
329,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
329,4,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
330,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
330,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
331,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
331,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
332,1,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
332,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
332,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
332,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
332,5,Splenic lesion,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
333,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
333,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
333,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
333,4,Pharyngeal disorder,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
333,5,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
333,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
334,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
334,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
334,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
334,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
334,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
335,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
335,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
335,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
335,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
336,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
336,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
336,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
336,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
336,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
336,6,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
337,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
337,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
337,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
337,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
338,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
338,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
338,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
338,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
338,5,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
338,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
339,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
339,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
339,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
339,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
339,5,Small intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
340,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
340,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
340,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
340,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
340,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
340,6,Tonsillar hypertrophy,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
341,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
341,2,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
341,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
341,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
342,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
342,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
342,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
342,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
342,5,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
342,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
343,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
343,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
343,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
344,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
344,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
344,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
344,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
344,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
345,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
345,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
345,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
345,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
345,5,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
346,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
346,2,Headache,Headaches NEC,Headaches,Nerv,N
346,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
346,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
346,5,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
346,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
347,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
347,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
347,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
347,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
347,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
348,1,Odynophagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
348,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
348,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
348,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
349,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
349,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
349,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
350,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
350,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
350,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
351,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
352,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
352,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
352,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
353,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
353,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
354,1,Anterior segment ischaemia,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
354,2,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
354,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
354,4,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
355,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
356,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
356,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
357,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
358,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
359,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
360,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
361,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
362,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
363,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
364,1,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
365,1,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
365,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
366,1,Autoimmune myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
366,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
367,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
367,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
368,1,Acute motor-sensory axonal neuropathy,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
369,1,Mononeuropathy multiplex,Mononeuropathies,Peripheral neuropathies,Nerv,N
370,1,Areflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
370,2,Axonal neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
370,3,Cachexia,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
370,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
370,5,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
370,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
370,7,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
371,1,Acute motor-sensory axonal neuropathy,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
372,1,Enterocolitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
372,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
373,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
374,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
374,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
374,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
375,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
375,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
375,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
375,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
375,5,Disturbance in social behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
375,6,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
375,7,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
375,8,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
375,9,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
375,10,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
375,11,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
375,12,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
375,13,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
375,14,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
376,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
377,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
378,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
379,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
379,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
380,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
381,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
381,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
381,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
382,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
382,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
382,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
383,1,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
383,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
383,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
384,1,Adenoviral encephalitis,Adenoviral infections,Viral infectious disorders,Infec,N
384,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
384,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
384,4,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
384,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
384,6,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
384,7,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
385,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
385,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
385,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
386,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
387,1,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
387,2,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
388,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
389,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
389,2,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
389,3,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
390,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
390,2,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
390,3,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
391,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
392,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
392,2,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
392,3,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
393,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
393,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
393,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
393,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
393,5,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
394,1,Aspiration bone marrow,Bone marrow and immune tissue histopathology procedures,Haematology investigations (incl blood groups),Inv,N
394,2,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
394,3,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
394,4,Osteolysis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
395,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
395,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
395,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
395,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
395,5,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
396,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
396,2,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
396,3,Delayed ischaemic neurological deficit,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
396,4,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
396,5,Pulseless electrical activity,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
